AbbVie Stock: Why A New FDA Order Hit It Harder Than Rivals Pfizer, Lilly – Investors Business Daily

AbbVie stock tumbled to a three-month low Wednesday after the Food and Drug Administration said it would have to add a warning to the label for arthritis drug Rinvoq.
XThe order also applies to drug… [+2780 chars]